Suki Toguchi is the Executive Director, Global Head of Technical Ops IT at Kite Pharma, a leading biopharmaceutical company with a singular focus on cell therapy — the use of genetically modified immune cells programmed to target tumors — which we believe has the potential to change the way cancer is treated. She has been with Gilead/Kite for over 8 years and leads the IT function for Kite’s Technical Operations which includes Manufacturing, Supply Chain, Quality, Process Development, Facilities & Engineering and Business Operations. She is the co-chair of the Gilead Asian Interest Network (GAIN) Employee Resource Group (ERG) and founded the Women at Gilead (W@G) Women in Technology (WIT) chapter. Prior to joining Gilead Sciences in 2012, Suki was a Senior Manager in the IT Advisory practice at Ernst & Young. She started her career at Arthur Andersen where she was an IT risk management consultant. Suki previously served on the Board of Directors of Wu Yee Children’s Services for 5 years.
Suki holds a Bachelors’ degree in Business Administration from the University of Michigan and an MBA from Wharton School, University of Pennsylvania.